Clinical presentation, molecular analysis and follow-up of patients with mut methylmalonic acidemia in Shandong province, China

被引:13
|
作者
Han, Bingjuan [1 ]
Nie, Wenying [1 ]
Sun, Meng [1 ]
Liu, Yingxia [1 ,2 ]
Cao, Zhiyang [3 ]
机构
[1] Jinan Maternal & Child Care Hosp, Jinan 250001, Shandong, Peoples R China
[2] Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Nanjing Jiangning Hosp, Nanjing 211100, Jiangsu, Peoples R China
来源
PEDIATRICS AND NEONATOLOGY | 2020年 / 61卷 / 02期
关键词
follow-up; isolated methylmalonic acidemia; methylmalonyl-CoA mutase; MUT; IDENTIFICATION; MUTATIONS; SPECTRUM; ACIDURIA; GENE;
D O I
10.1016/j.pedneo.2019.07.004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The mut methylmalonic acidemia (MMA) caused by the deficiency of methylmalonyl-CoA mutase (MCM) activity, which results from defects in the MUT gene. The aim of this study was to summarize the clinical and biochemical data, spectrum of mutations, treatment regime and follow-up of patients with mut MMA from Jan 2013 to Dec 2017 in Shandong province, China. Methods: Twenty patients were diagnosed with isolated mut MMA by elevated C3, C3/C2, and urine methylmalonic acid levels without hyperhomocysteinemia. The MUT gene was amplified and sequenced. Most patients received treatment with specific medical nutrition and oral L-carnitine after diagnosis. Metabolic parameters, clinical presentation and mental development were followed up. Results: Among 20 patients with mut MMA, 14 had clinical presentations, and 12 presented in the neonatal period. Three patients died of metabolic crises triggered by infection. Twenty-three different mutations were detected, and four mutations (c.613G > A, c.446A > G, c.920-923delTCTT and c.1359delT) were novel. Most patients received timely treatment and had favorable metabolic responses, with reductions in C3, C3/C2 and urine MMA. We obtained 16 records of DQ/IQ assessments. Six patients exhibited normal development, but ten patients suffered from neurological symptoms of varying degrees and had low DQ/IQ scores. Conclusion: Our study contributes toward expanding the knowledge of the genetic basis of mut MMA. The c.914T > C was the most frequent mutation, and four novel mutations were detected. Patients diagnosed by newborn screening and treated at the presymptomatic stage may have better outcomes. However, these limited data do not allow any definitive statements on possible genotypeephenotype correlations that can influence the outcomes of mut MMA. Nonetheless, it is necessary for high-risk families to have early prenatal diagnoses. Copyright (C) 2019, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 50 条
  • [1] Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes
    Hao, Lili
    Ling, Shiying
    Ding, Si
    Qiu, Wenjuan
    Zhang, Huiwen
    Zhang, Kaichuang
    Chen, Ting
    Gu, Xuefan
    Liang, Lili
    Han, Lianshu
    PEDIATRIC RESEARCH, 2024,
  • [2] Screening for Methylmalonic and Propionic Acidemia: Clinical Outcomes and Follow-Up Recommendations
    Held, Patrice K.
    Singh, Emily
    Schwoerer, Jessica Scott
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2022, 8 (01)
  • [3] Diagnosis, treatment and follow-up of patients with tetrahydrobiopterin deficiency in Shandong province, China
    Han, Bingjuan
    Zou, Hui
    Han, Bingchao
    Zhu, Weiwei
    Cao, Zhiyang
    Liu, Yingxia
    BRAIN & DEVELOPMENT, 2015, 37 (06): : 592 - 598
  • [4] Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cb1C type) in Shandong province, China
    Han, Bingjuan
    Cao, Zhiyang
    Tian, Liping
    Zou, Hui
    Yang, Lian
    Zhu, Weiwei
    Liu, Yingxia
    BRAIN & DEVELOPMENT, 2016, 38 (05): : 491 - 497
  • [5] LONG-TERM FOLLOW-UP OF 77 PATIENTS WITH ISOLATED METHYLMALONIC ACIDEMIA
    BAUMGARTER, ER
    VIARDOT, C
    JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (02) : 138 - 142
  • [6] Clinical and Molecular Spectrum of Patients with Methylmalonic Acidemia
    Gupta, Neerja
    Endrakanti, Mounika
    Bhat, Meenakshi
    Rao, Nivedita
    Kaur, Ravneet
    Kabra, Madhulika
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (07): : 675 - 681
  • [7] Clinical outcomes of patients with mut-type methylmalonic acidemia identified through expanded newborn screening in China
    Ling, Shiying
    Wu, Shengnan
    Shuai, Ruixue
    Yu, Yue
    Qiu, Wenjuan
    Wei, Haiyan
    Yang, Chiju
    Xu, Peng
    Zou, Hui
    Feng, Jizhen
    Niu, Tingting
    Hu, Haili
    Zhang, Huiwen
    Liang, Lili
    Wang, Yu
    Chen, Ting
    Xu, Feng
    Gu, Xuefan
    Han, Lianshu
    HUMAN GENOMICS, 2024, 18 (01)
  • [8] GENETIC ANALYSIS OF MUT, MMAA, AND MMAB IN THAI PATIENTS WITH ISOLATED METHYLMALONIC ACIDEMIA
    Vatanavicharn, N.
    Champattanachai, V
    Liammongkolkul, S.
    Sawangareetrakul, P.
    Keeratichamroen, S.
    Cairns, J. R. K.
    Srisomsap, C.
    Sathienkijkanchai, A.
    Svasti, J.
    Wasant, P.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S42 - S42
  • [9] Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China
    Wang, Fei
    Han, Lianshu
    Yang, Yanling
    Gu, Xuefan
    Ye, Jun
    Qiu, Wenjuan
    Zhang, Huiwen
    Zhang, Yafen
    Gao, XiaoLan
    Wang, Yu
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S435 - S442
  • [10] MOLECULAR AND STRUCTURAL ANALYSIS OF SIX NONSENSE MUTATIONS IN MUT METHYLMALONIC ACIDEMIA PATIENTS INCLUDING TWO NOVEL NONSENSE MUTATIONS
    Dundar, H.
    Ozgul, R. K.
    Unal, O.
    Karaca, M.
    Aydin, H., I
    Tokatli, A.
    Sivri, H. S.
    Coskun, T.
    Dursun, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S177 - S177